Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, supplying secure, large-purity components for aging and cancer investigation. every day laboratory workflows normally expose a persistent problem: the gradual and inefficient removing of senescent cells that impair tissue